title: Plant alkaloids that cause developmental defects through the disruption of cholinergic neurotransmission.
abstract: The exposure of a developing embryo or fetus to alkaloids from plants, plant products, or plant extracts has the potential to cause developmental defects in humans and animals. These defects may have multiple causes, but those induced by piperidine and quinolizidine alkaloids arise from the inhibition of fetal movement and are generally referred to as multiple congenital contracture-type deformities. These skeletal deformities include arthrogyrposis, kyposis, lordosis, scoliosis, and torticollis, associated secondary defects, and cleft palate. Structure-function studies have shown that plant alkaloids with a piperidine ring and a minimum of a three-carbon side-chain α to the piperidine nitrogen are teratogenic. Further studies determined that an unsaturation in the piperidine ring, as occurs in gamma coniceine, or anabaseine, enhances the toxic and teratogenic activity, whereas the N-methyl derivatives are less potent. Enantiomers of the piperidine teratogens, coniine, ammodendrine, and anabasine, also exhibit differences in biological activity, as shown in cell culture studies, suggesting variability in the activity due to the optical rotation at the chiral center of these stereoisomers. In this article, we review the molecular mechanism at the nicotinic pharmacophore and biological activities, as it is currently understood, of a group of piperidine and quinolizidine alkaloid teratogens that impart a series of flexure-type skeletal defects and cleft palate in animals.
authors: United States Department of Agriculture, Poisonous Plant Research Laboratory, Agricultural Research Service, 1150 E 1400 N, Logan, Utah, 84321.
authors: Benedict T
authors: BT
authors: Green
authors: Stephen T
authors: ST
authors: Lee
authors: Kevin D
authors: KD
authors: Welch
authors: Kip E
authors: KE
authors: Panter
mesh_terms: D000470:Alkaloids / Q000633:toxicity*; D000818:Animals; D018678:Cholinergic Agents / Q000494:pharmacology*; D006801:Humans; D010880:Piperidines / Q000633:toxicity; D011725:Pyridines / Q000633:toxicity; D054837:Quinolizidines / Q000633:toxicity; D011950:Receptors, Cholinergic / Q000187:drug effects*; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission / Q000187:drug effects*; D013723:Teratogens / Q000633:toxicity
chemical_list: D000470:Alkaloids; D018678:Cholinergic Agents; D010880:Piperidines; D011725:Pyridines; D054837:Quinolizidines; D011950:Receptors, Cholinergic; D013723:Teratogens; C032727:piperidine; C023666:pyridine
keywords: TrpB; desensitization; nicotinic acetylcholine receptor; piperidine alkaloids; pyridine alkaloids